RVL Pharmaceuticals plc
RVLPQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.30% | -26.72% | -25.45% | 117.97% | 4.07% |
| Total Receivables | 2.82% | -38.01% | -7.59% | 78.94% | -89.57% |
| Inventory | 536.62% | -72.83% | 26.25% | 17.61% | -36.99% |
| Prepaid Expenses | -8.70% | -57.99% | 18.68% | -21.82% | -25.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -46.18% |
| Total Current Assets | -32.85% | -32.69% | -19.66% | 76.45% | -32.26% |
|
|
|||||
| Total Current Assets | -32.85% | -32.69% | -19.66% | 76.45% | -32.26% |
| Net Property, Plant & Equipment | 26.45% | 68.29% | 29.19% | -12.63% | -17.63% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | 0.00% | -48.92% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -23.13% | -13.54% | -17.28% | 24.45% | -13.50% |
|
|
|||||
| Total Accounts Payable | -3.80% | 9.26% | -65.63% | 28.80% | 14.90% |
| Total Accrued Expenses | -8.72% | -44.66% | 5.97% | 15.40% | -18.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,197.40% | 137.99% | 260.96% | -55.17% | -47.32% |
| Total Finance Division Other Current Liabilities | -40.65% | -5.69% | 57.61% | 32.48% | 19.39% |
| Total Other Current Liabilities | -40.65% | -5.69% | 57.61% | 32.48% | 19.39% |
| Total Current Liabilities | 316.82% | -16.81% | -8.20% | 15.79% | -12.85% |
|
|
|||||
| Total Current Liabilities | 316.82% | -16.81% | -8.20% | 15.79% | -12.85% |
| Long-Term Debt | -- | -4.43% | -0.72% | 30.30% | -4.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -21.31% | 117.86% | -53.33% | -31.23% | -26.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -65.14% | -31.94% | -77.33% | 103.43% | -43.24% |
| Total Liabilities | -2.85% | -8.15% | -10.82% | 30.90% | -11.37% |
|
|
|||||
| Common Stock & APIC | 0.03% | 0.08% | 0.14% | 4.11% | 0.19% |
| Retained Earnings | -4.11% | -2.04% | -3.33% | -2.69% | -2.31% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -59.19% | -21.71% | -25.46% | 17.15% | -15.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -59.19% | -21.71% | -25.46% | 17.15% | -15.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -59.19% | -21.71% | -25.46% | 17.15% | -15.79% |
|
|
|||||